National Health Investors (NYSE:NHI) Updates FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.37-4-43 for the period, compared to the consensus EPS estimate of $4.35.

National Health Investors Stock Up 1.5 %

NHI opened at $65.19 on Tuesday. The stock’s fifty day moving average is $60.67 and its 200-day moving average is $56.36. National Health Investors has a one year low of $48.51 and a one year high of $65.23. The company has a market capitalization of $2.83 billion, a PE ratio of 20.63 and a beta of 0.95. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 5.52%. The ex-dividend date was Wednesday, March 27th. National Health Investors’s payout ratio is 115.02%.

Wall Street Analyst Weigh In

NHI has been the topic of a number of research reports. Truist Financial boosted their target price on shares of National Health Investors from $55.00 to $58.00 and gave the stock a hold rating in a report on Thursday, April 4th. BMO Capital Markets upgraded National Health Investors from a market perform rating to an outperform rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. StockNews.com cut National Health Investors from a buy rating to a hold rating in a report on Thursday, April 18th. Wedbush upped their target price on National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $69.00 price target on the stock. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $60.50.

Insider Activity at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford bought 10,000 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the acquisition, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 8.21% of the stock is owned by insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.